Glucagon-like peptide 1 receptor agonists (GLP-1RAs), traditionally used in the treatment of type 2 diabetes, are becoming increasingly appreciated for their diverse applications
Ozempic: the truth about new weight-loss drugs Wegovy study finds weight-loss drug sharply cuts heart attacks, strokes and cardiac deaths What to do about fake weight-loss drugs and compounded versions Nutrition is vital when taking GLP-1 weight-loss drugs
They include: feeling or being sick diarrhoea constipation These side effects are more likely to occur when the treatment first starts or when the dose increases
Weight, glucose parameters, and adverse effect assessment inform protocol adjustments
Metabolic Syndrome and Retatrutide : Metabolic syndrome is a cluster of conditions, including high blood pressure, high blood sugar, abnormal cholesterol levels, and excess abdominal fat, that significantly increase the risk of developing cardiovascular disease and type 2 diabetes
